RETROSPECTIVE AND PROSPECTIVE STUDY OF STAGE PRESENTATION OF CARCINOMA BREAST IN TERTIARY HEALTH CARE CENTRE, INDORE
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2015, Vol 2, Issue 17
Abstract
Breast cancer is most common cause of death in middle aged women today in most of developed cities of India, and up to some extent in rural areas. Significant change is observed during last two decades in distribution of ca breast in India. In this paper, our proposed work focuses on identifying stage of ca breast along with age at which patient is diagnosed as ca breast. This paper also analyzes ca breast ratio for rural and urban population. Then we also tried to find out menstrual status of patients and chief complaints associated with ca breast patients at that particular stage. AIMS OF THE STUDY: The aim of this paper is to document the patient characteristics, stage at presentation of breast carcinoma. To identify specific age group and distribution of ca breast in females. To estimate the disease load on the community. SETTINGS & DESIGN: This was retrospective and prospective study n=400 cases of carcinoma breast. METHODS & MATERIALS: Only FNAC or biopsy proven cases was included in the study. Patients were evaluated in reference to the risk factors i.e. age, menstrual history, breast feeding, OCP/HRT, H/O other malignancy and stage of presentation at the time of diagnosis. For proper staging triple assessment was done, triple assessment included clinical examination, imaging and histopathological examination. Metastatic work done by using LFTs, USG abdomen & chest, X-ray chest & spine and bone scan/CT brain if needed. RESULTS & CONCLUSION: There is significant difference in age at the time of diagnosis and stage distribution of the patients. Mean age of presentation is 40 years, which is ten years earlier as compared to other studies. Bulk of the patients around 55% fell between 30-50 years age group. In stage presentation, maximum patients came under stage II which was 45%,while there were 38% of patients in stage III, 16% patients were fell in stage IV, only 1% patients were found in stage I and none of pt were diagnosed under stage 0. Lymph node metastasis was found in 63% of patients. In view of menstruation 67% of pts were postmenopausal, 18% perimenopausal and 15% were menstruating. According to location 66.5% patients were from rural and 33.5% belong to urban area. There is significant difference in age of distribution and stage of presentation of carcinoma breast, which indicates impact of risk factors and awareness towards the carcinoma breast in our developing country.
Authors and Affiliations
Sonia Moses, Sapna Shukla, Imran Khan Mansoori
Keywords
Related Articles
- EP ID EP227304
- DOI 10.18410/jebmh/2015/362
- Views 54
- Downloads 0
SUICIDAL HANGING IN URBAN YOUTH: A PROSPECTIVE STUDY
BACKGROUND: Suicide is among the top three causes of death among youth worldwide. Hanging is among the most common modes of suicide. OBJECTIVES: The purpose of this prospective study is to determine the Suicidal hanging...
COMPLETE FUSION OF FIFTH LUMBAR VERTEBRA WITH SACRUM: AN OSTEOLOGICAL CASE REPORT
Lumbosacral region of the body not only protects the spinal cord and related structures but also transmit the body weight to lower extremity and maintains the body posture. Sacralization of the 5th lumbar vertebrae, is a...
BLADDER PERFORATION WITH INTRAUTERINE CONTRACEPTIVE DEVICE
The intrauterine contraceptive device is a common method of contraception among reproductive aged women because of its low cost and high efficacy. Perforation of the bladder by an intrauterine device is extremely rare. W...
SONOGRAPHIC PREDICTION OF SCAR DEHISCENCE IN WOMEN WITH PREVIOUS CAESAREAN SECTION
BACKGROUND Caesarean section (Sectio Caesarea) is a surgical method for the completion of delivery. After various historical modifications of operative techniques, modern approach consists in the transverse dissection of...
EFFICACY OF CANAGLIFLOZIN AS AN ADD-ON TO TRIPLE DRUG TREATMENT WITH GLIMEPIRIDE, METFORMIN AND TENELIGLIPTIN
BACKGROUND Canagliflozin is a well-tolerated sodium-glucose transporter 2 inhibitor, with remarkable efficacy in providing glycaemic control in patients with type 2 diabetes mellitus (T2DM). However, limited evidence is...